Menarini

Oct 12, 2018

The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries

Sep 19, 2018

Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for MEN1112/OBT357 at the 60th Annual SIC Meeting

Aug 06, 2018

Menarini Ricerche to Sponsor Cancer Trial in Acute Myeloid Leukemia in USA

Jun 01, 2018

Menarini Ricerche to Present the Study Design of CD205-Shuttle, a First-in-human Trial of MEN1309/OBT076, at the ASCO Annual Meeting 2018

Apr 13, 2018

Menarini Ricerche to Present the Most Recent Pre-clinical Data About the PI3K Inhibitor MEN1611 at the AACR Annual Meeting 2018

Apr 03, 2018

TraceLink Unveils Industry Speakers for FutureLink Munich, Including Leaders from Santen, Leadiant Biosciences, NHS and Menarini

Mar 12, 2018

Menarini Hires Their 17,000th Employee

Sep 28, 2017

Menarini Ricerche Attended the Brainstorming Meeting on CD38 and CD157 which was Held on September 21st-23rd 2017 at San Benedetto Po and Mantova (Italy)

Sep 12, 2017

Oncology Research: New Opportunities for Menarini and OBT

Jun 29, 2017

Menarini Increases Number of Members of the Board - for the First Time External Members In Majority

Jun 21, 2017

Menarini Ricerche to Present the Most Recent Data About the Pre-clinical Development of its Novel ADC MEN1309/OBT076 at the 29th Pezcoller Symposium

Jun 07, 2017

Menarini Expands its Capabilities for Antibody Drug Conjugate (ADC) Projects